Comorbid fibromyalgia: A qualitative review of prevalence and importance

  title={Comorbid fibromyalgia: A qualitative review of prevalence and importance},
  author={Mary-Ann Fitzcharles and Serge Perrot and Winfried H{\"a}user},
  journal={European Journal of Pain},
Fibromyalgia (FM) may be an unrecognized cause of suffering for persons with an array of medical conditions. This is especially true for illness that is characterized by pain of any nature. Once believed to be a unique diagnosis, FM is recently reported to occur concomitantly with various rheumatic diseases, and importantly adversely impacts global health status. However, there is increasing report of FM associated with other diseases that are not defined by chronic pain. This qualitative… 
Fibromyalgia in Older Individuals
As FM is most often a lifelong condition, patients should be encouraged to identify their own personal strategies that can attenuate symptoms, especially when symptoms flare, and Continued life participation should be the outcome goal.
Fibromyalgia and psoriatic arthritis: Partners together
  • G. Littlejohn
  • Medicine
    International journal of rheumatic diseases
  • 2021
This issue of the Journal 2 studies addresses fibromyalgia in patients with psoriatic arthritis (PsA), a condition which affects up to 1% of the population, and highlights the disconnect between subjective patient-reported symptoms and objective measures of disease activity.
The economic burden of fibromyalgia: A systematic literature review.
Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria.
One of the highest prevalence rates of fibromyalgia ever reported in the general population was revealed in Syria, revealing its risk factors including unemployment, unemployment, and irritable bowel syndrome were significant risk factors for FM.
The impact of the presence of fibromyalgia on fatigue in patients with psoriatic arthritis: comparison with controls
It was observed that FM presence and fatigue were more common in PsA patients than controls and comorbid FM had significant effect on fatigue in these patients.
Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015–2019)
Although the critically reviewed studies superficially suggest that medical cannabis is a safe and effective treatment for fibromyalgia pain, serious methodological limitations prevent a definitive conclusion regarding the use of cannabinoids for pain management in Fibromyalgia patients at this time.
Fibromyalgia in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: prevalence and screening
The prevalence of FM among SAPHO patients was similar to that among patients with other rheumatic diseases, and concomitant FM in SaphO syndrome was associated with older age, widespread pain, and worse PROs.
The Case for Comorbid Myofascial Pain—A Qualitative Review
  • S. VulfsonsA. Minerbi
  • Medicine, Psychology
    International journal of environmental research and public health
  • 2020
The evidence of comorbid myofascial pain has been observed in a wide variety of medical conditions, including malignant tumors, osteoarthritis, neurological conditions, and mental health conditions.
Common and Contrasting Characteristics of the Chronic Soft-Tissue Pain Conditions Fibromyalgia and Lipedema
Disease perception is more pronounced in fibromyalgia than in lipedema, especially in social and role dysfunction, whereas the walking distance was similar for both syndromes, which may be explicable by limited coping skills in Fibromyalgia.


Fibromyalgia and coeliac disease: a media hype or an emerging clinical problem?
A serological screening for CD is not recommended in FM patients but rather a case-finding strategy should be performed and proposals of GFD inFM patients, in absence of a well-established diagnosis of CD, should be rigorously avoided.
Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity
The prevalence of FM in patients with rheumatologic diseases was found to be 6.6%, and there were significant correlations between disease activity indexes and Fibromyalgia Impact Questionnaire scores for most r heumatologic patients (RA, AS, OA, and BD).
Fibromyalgia in patients with thyroid autoimmunity: prevalence and relationship with disease activity
A strong positive correlation was noted between fibromyalgia impact questionnaire (FIQ) scores and disease duration, age, values of thyroid-stimulating hormone (TSH) and T POAb, waist circumference and marital status, and TPOAb was found to be independent of body mass index, age and TSH.
Fibromyalgia has a high prevalence and impact in cardiac failure patients.
High prevalence of FM was found in patients with CCF, and this was associated with increased likelihood of other comorbid central sensitivity syndromes and with poorer clinical outcomes.
Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: a cross sectional population survey.
The prevalences of FM and CWP in patients with IBD were similar to those of the general population, and chronic idiopathic inflammation of the intestine does not appear to predispose to chronic widespread pain.
Fibromyalgia in patients with irritable bowel syndrome
The presence of FM in IBS patients seems to be associated only with the severity of IBS, which confirms previous studies on the association between the two syndromes.
Fibromyalgia in inflammatory bowel disease.
Recognizing FM in patients with IBD will prevent misdiagnosis and ensure correct treatment, and the lower pain threshold in Crohn's disease may suggest a disease-specific effect.
Rheumatoid Arthritis and Fibromyalgia: A Frequent Unrelated Association Complicating Disease Management
DAS28 overestimated objective RA severity in patients who also had FM, and this association does not appear to be a marker of worse prognosis, but rather a fortuitous association between the 2 diseases and one that may afford these patients some protection against joint destruction.
The impact of pain on systemic rheumatic diseases.